BRIEF-Intelgenx secures a license for tadalafil erectile dysfunction dosing patent

* Intelgenx Technologies - announced signing of binding term

sheet for license to Eli Lilly and co's tadalafil dosing patent,

U.S. patent no. 6,943,166

Read more